Get the Stockscreener App
20.20
3.11%
0.61
Cidara Therapeutics Inc Stock (CDTX) Forecast
The Cidara Therapeutics Inc (CDTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $17.01, representing a -15.81% decrease from the current price of $20.20. The highest analyst price target is $17.52, and the lowest is $16.49.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CDTX Price Target
Average 20.93
(+3.63% Upside)
Is Cidara Therapeutics Inc (CDTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 76.61 | Sell |
| STOCH(9,6) | 73.87 | Neutral |
| STOCHRSI(14) | 50.28 | Neutral |
| MACD(12,26) | 1.9252 | Buy |
| ADX(14) | 65.58 | Buy |
| William %R | -12.91 | Sell |
| CCI(14) | 114.58 | Buy |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
17.09
Buy
|
17.58
Buy
|
| MA20 |
15.19
Buy
|
15.87
Buy
|
| MA50 |
12.76
Buy
|
13.86
Buy
|
| MA100 |
12.47
Buy
|
13.14
Buy
|
| MA200 |
13.13
Buy
|
13.52
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, CDTX could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 2 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on CDTX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 76.61 indicates that CDTX is overbought. This suggests that CDTX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 73.87 indicates that CDTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 50.28 indicates that CDTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 65.58 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 114.58 indicates that CDTX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term CDTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cidara Therapeutics Inc financial reports and earnings history, Cidara Therapeutics Inc (CDTX) stock could reach $22.66 by 2030, $138.09 by 2040 and $178.03 by 2050. See the projected annual prices until 2050 of the Cidara Therapeutics Inc stock below:
- Cidara Therapeutics Inc (CDTX) is expected to reach an average price of $102.53 in 2035, with a high prediction of $102.61 and a low estimate of $101.31. This indicates an $407.58% rise from the last recorded price of $20.20.
- Cidara Therapeutics Inc (CDTX) stock is projected to chart a bullish course in 2040, with an average price target of $137.96, representing an $582.98% surge from its current level. The forecast ranges from a conservative $136.62 to a sky-high $138.09.
- Our analysts predict Cidara Therapeutics Inc (CDTX) to jump 705.89% by 2045, soaring from $160.95 to an average price of $162.79, potentially reaching $162.87. While $160.95 is the low estimate, the potential upside is significant.
- Cidara Therapeutics Inc (CDTX) stock is expected to climb by 2050, reaching an average of $177.99, a $781.12% jump from its current level. However, a wide range of estimates exists, with high and low targets of $178.03 and $175.49, respectively, highlighting the market's uncertainty.
Cidara Therapeutics Inc Stock (CDTX) Year by Year Forecast
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2024
Our forecast for CDTX stock price in 2024 now indicates an average price target of $9.0096 with a high forecast of $17.52 and a low forecast of $0.5002. The average prediction reflects an decrease of -55.40% from the last recorded price of $20.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $17.48 | $16.49 | $17.52 | -13.47% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2025
Cidara Therapeutics Inc Stock (CDTX) is expected to reach an average price of $21.80 in 2025, with a high prediction of $26.16 and a low estimate of $17.44. This indicates an +7.93% rise from the last recorded price of $20.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $19.04 | $17.44 | $19.59 | -5.73% |
| February, 2025 | $19.38 | $19.02 | $20.67 | -4.05% |
| March, 2025 | $19.67 | $19.25 | $20.01 | -2.62% |
| April, 2025 | $20.07 | $18.62 | $20.45 | -0.67% |
| May, 2025 | $21.03 | $20.06 | $21.12 | +4.13% |
| June, 2025 | $21.85 | $21.15 | $22.46 | +8.19% |
| July, 2025 | $23.61 | $22.04 | $23.81 | +16.87% |
| August, 2025 | $24.01 | $23.53 | $24.24 | +18.85% |
| September, 2025 | $24.77 | $23.72 | $24.96 | +22.61% |
| October, 2025 | $24.73 | $24.62 | $25.37 | +22.43% |
| November, 2025 | $25.12 | $24.65 | $25.36 | +24.36% |
| December, 2025 | $25.65 | $25.22 | $26.16 | +27.00% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2026
The predicted value for Cidara Therapeutics Inc (CDTX) in 2026 is set at an average of $29.33. Estimates vary from a peak of $33.48 to a trough of $25.17, indicating an +45.19% surge from the present price of $20.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $25.99 | $25.17 | $26.23 | +28.68% |
| February, 2026 | $26.34 | $26.07 | $26.52 | +30.41% |
| March, 2026 | $27.25 | $26.41 | $27.35 | +34.91% |
| April, 2026 | $28.44 | $27.40 | $28.83 | +40.77% |
| May, 2026 | $28.78 | $28.05 | $29.04 | +42.45% |
| June, 2026 | $29.21 | $28.66 | $29.99 | +44.63% |
| July, 2026 | $29.70 | $29.15 | $29.79 | +47.02% |
| August, 2026 | $30.47 | $29.77 | $30.55 | +50.83% |
| September, 2026 | $30.98 | $30.48 | $31.11 | +53.38% |
| October, 2026 | $31.38 | $30.70 | $31.46 | +55.35% |
| November, 2026 | $32.62 | $31.48 | $32.62 | +61.49% |
| December, 2026 | $33.33 | $32.62 | $33.48 | +64.98% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cidara Therapeutics Inc (CDTX) is $36.43, with a high forecast of $39.88 and a low forecast of $32.98. This indicates an +80.37% increase from the last price of $20.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $33.26 | $32.98 | $33.60 | +64.67% |
| February, 2027 | $33.83 | $33.39 | $34.09 | +67.49% |
| March, 2027 | $34.56 | $33.80 | $34.81 | +71.08% |
| April, 2027 | $34.69 | $34.56 | $34.98 | +71.74% |
| May, 2027 | $35.18 | $34.71 | $35.36 | +74.18% |
| June, 2027 | $35.80 | $35.26 | $35.87 | +77.25% |
| July, 2027 | $36.57 | $35.92 | $36.80 | +81.05% |
| August, 2027 | $37.13 | $36.74 | $37.22 | +83.81% |
| September, 2027 | $37.59 | $37.18 | $37.63 | +86.09% |
| October, 2027 | $38.23 | $37.74 | $38.32 | +89.24% |
| November, 2027 | $39.04 | $38.40 | $39.09 | +93.27% |
| December, 2027 | $39.78 | $39.20 | $39.88 | +96.93% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2028
In 2028, Cidara Therapeutics Inc (CDTX) is projected to reach an average price of $44.15, with a high projection of $48.37 and a low estimate of $39.93. This indicates an +118.55% rise from the last price of $20.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $40.47 | $39.93 | $40.50 | +100.34% |
| February, 2028 | $41.01 | $40.55 | $41.06 | +103.03% |
| March, 2028 | $41.77 | $41.08 | $41.80 | +106.79% |
| April, 2028 | $42.47 | $41.87 | $42.51 | +110.26% |
| May, 2028 | $43.23 | $42.54 | $43.24 | +114.01% |
| June, 2028 | $43.95 | $43.27 | $44.77 | +117.59% |
| July, 2028 | $45.42 | $44.12 | $45.59 | +124.85% |
| August, 2028 | $46.12 | $45.42 | $46.40 | +128.33% |
| September, 2028 | $46.38 | $45.96 | $46.97 | +129.62% |
| October, 2028 | $46.85 | $46.40 | $46.88 | +131.94% |
| November, 2028 | $47.89 | $46.99 | $47.94 | +137.06% |
| December, 2028 | $48.33 | $47.94 | $48.37 | +139.23% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2029
The 2029 price forecast for Cidara Therapeutics Inc Stock (CDTX) is $45.60 on average, with a high prediction of $69.74 and a low estimate of $21.46. This represents an +125.75% increase from the previous price of $20.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $48.96 | $48.43 | $48.99 | +142.40% |
| February, 2029 | $49.36 | $49.06 | $49.46 | +144.37% |
| March, 2029 | $50.28 | $49.49 | $50.35 | +148.90% |
| April, 2029 | $50.75 | $50.34 | $50.85 | +151.22% |
| May, 2029 | $51.37 | $50.81 | $51.42 | +154.31% |
| June, 2029 | $52.00 | $51.35 | $52.01 | +157.43% |
| July, 2029 | $52.63 | $52.10 | $52.67 | +160.56% |
| August, 2029 | $53.26 | $52.75 | $53.32 | +163.64% |
| September, 2029 | $53.93 | $53.39 | $53.96 | +167.00% |
| October, 2029 | $54.78 | $54.06 | $54.83 | +171.21% |
| November, 2029 | $55.31 | $54.88 | $55.67 | +173.80% |
| December, 2029 | $21.54 | $21.46 | $69.74 | +6.63% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2030
Cidara Therapeutics Inc Stock (CDTX) is expected to reach an average price of $29.88 in 2030, with a high forecast of $38.06 and a low forecast of $21.69. This signifies an +47.90% surge from the last price of $20.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.56 | $21.69 | $22.66 | +11.67% |
| February, 2030 | $23.95 | $22.86 | $23.97 | +18.57% |
| March, 2030 | $24.84 | $24.15 | $25.36 | +22.95% |
| April, 2030 | $26.45 | $25.03 | $26.57 | +30.96% |
| May, 2030 | $28.27 | $27.07 | $28.27 | +39.96% |
| June, 2030 | $29.41 | $28.38 | $29.46 | +45.57% |
| July, 2030 | $31.39 | $29.72 | $31.50 | +55.39% |
| August, 2030 | $32.71 | $31.57 | $32.93 | +61.92% |
| September, 2030 | $35.06 | $33.01 | $35.50 | +73.54% |
| October, 2030 | $36.07 | $34.95 | $36.90 | +78.58% |
| November, 2030 | $36.59 | $36.31 | $37.45 | +81.15% |
| December, 2030 | $38.01 | $35.93 | $38.06 | +88.17% |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):